Mobile

The purpose of this study is to test the effectiveness of switching from ABC/3TC to F/TAF FDC versus continuing on ABC/3TC in HIV-1 infected subjects who are virologically suppressed. The safety and h...

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000871-28

The purpose of this study is to test the effectiveness of switching from ABC/3TC to F/TAF FDC versus continuing on ABC/3TC in HIV-1 infected subjects who are virologically suppressed. The safety and how well both the F/TAF FDC and ABC/3TC are tolerated will also be evaluated

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of switching ABC/3TC to F/TAF versus maintaining ABC/3TC in HIV-1 infected subjects who are virologically suppressed on regimens containing ABC/3TC as determined by the proportion of subjects with HIV-1 RNA < 50 copies/mL at Week 48

Critère d'inclusion

  • human immunodeficiency virus-1 (HIV-1)

Liens